Zelnorm (tegaserod), a new drug for irritable bowel syndrome
September 2002
Novartis is now marketing Zelnorm (tegaserod), a new drug for irritable bowel syndrome.
Zelnorm is the first in a new class...5-HT4 serotonin partial agonist. It STIMULATES bowel motility to reduce abdominal pain...bloating...and constipation. It's for CONSTIPATION-predominant IBS.
This is different from Lotronex, which is a 5-HT3 serotonin antagonist that SLOWS bowel motility...for DIARRHEA-predominant IBS.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.